iHuman is an education & training services business based in the US. iHuman shares (IH) are listed on the NYSE and all prices are listed in US Dollars. iHuman employs 723 staff and has a trailing 12-month revenue of around $882.7 million.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
iHuman stock price (NYSE: IH)
Use our graph to track the performance of IH stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is iHuman stock undervalued or overvalued?
Valuing iHuman stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of iHuman's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
iHuman's P/E ratio
iHuman's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, iHuman shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, iHuman's P/E ratio is best considered in relation to those of others within the education & training services industry or those of similar companies.
Recently iHuman has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), iHuman shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In iHuman's case, that would currently equate to about $0 per share.
While iHuman's payout ratio might seem low, this can signify that iHuman is investing more in its future growth.
iHuman's most recent dividend payout was on 14 May 2025. The latest dividend was paid out to all shareholders who bought their shares by 16 April 2025 (the "ex-dividend date").
iHuman's dividend payout ratio is perhaps best considered in relation to those of similar companies.
Over the last 12 months, iHuman's shares have ranged in value from as little as $1.4701 up to $3.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while iHuman's is -0.058. This would suggest that iHuman's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, iHuman has bucked the trend.
To put iHuman's beta into context you can compare it against those of similar companies.
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China and internationally. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and iHuman Chinese Reading; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo series; and Aha World and Aha Makeover. It also provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity; and Cosmicrew, a 3D comedic adventure animation series. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China. .
Frequently asked questions
null What percentage of iHuman is owned by institutions? Currently 0.678% of iHuman shares are held by institutions.How many people work for iHuman? Latest data suggests 723 work at iHuman.When does the fiscal year end for iHuman? iHuman's fiscal year ends in December.Where is iHuman based? iHuman's address is: Building A, Beijing, China, 100102What is iHuman's ISIN number? iHuman's international securities identification number is: US45175B1098What is iHuman's CUSIP number? iHuman's Committee on Uniform Securities Identification Procedures number is: 45175B109
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
